Lobbying client
TITAN PHARMACEUTICALS, INC.
Pharmaceutical company
The register keeps a separate record of this client for every firm that files for it and every spelling of its name. All 2 of its records are shown together here.
Filings
25
Filed by
2
Reported in-house
—
Reported by firms
$160,000
Reported lobbying by year
The larger of in-house and firm-reported each year, $ thousands
2018 to 2021
Filings
25 filings, newest first.
| Filing | Filed by | Amount |
|---|---|---|
|
1st Quarter - Termination (No Activity) 1st Quarter 2021
|
HANCE SCARBOROUGH | — reported |
|
4th Quarter - Termination 4th Quarter 2020
|
THE LIVINGSTON GROUP, LLC | $10,000 reported |
|
4th Quarter - Report (No Activity) 4th Quarter 2020
|
HANCE SCARBOROUGH | — reported |
|
4th Quarter - Reportreplaced 4th Quarter 2020
|
THE LIVINGSTON GROUP, LLC | $20,000 reported |
|
3rd Quarter - Report 3rd Quarter 2020
|
THE LIVINGSTON GROUP, LLC | $20,000 reported |
|
3rd Quarter - Report (No Activity) 3rd Quarter 2020
|
HANCE SCARBOROUGH | — reported |
|
2nd Quarter - Report (No Activity) 2nd Quarter 2020
|
HANCE SCARBOROUGH | — reported |
|
2nd Quarter - Report 2nd Quarter 2020
|
THE LIVINGSTON GROUP, LLC | $20,000 reported |
|
1st Quarter - Report (No Activity) 1st Quarter 2020
|
HANCE SCARBOROUGH | — reported |
|
1st Quarter - Report 1st Quarter 2020
|
THE LIVINGSTON GROUP, LLC | $20,000 reported |
Filed by
Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.
| Firm | Reports | Amount |
|---|---|---|
| THE LIVINGSTON GROUP, LLC | 9 | $160,000 |
| HANCE SCARBOROUGH | 13 | — |
Issues lobbied
How many report sections named each issue, counting the current version of each report.
| Issue | Code | Mentions |
|---|---|---|
| Health Issues | HCR | 9 |
| Pharmacy | PHA | 8 |
| Budget/Appropriations | BUD | 7 |
| Medicare/Medicaid | MMM | 7 |
| Medical/Disease Research/Clinical Labs | MED | 7 |
Bills named in its filings
Bill numbers found in the filers' descriptions, most often named first.
| Bill | Congress | Times named |
|---|---|---|
| S. 2456 | 115th | 20 |
From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.